Responses to parliamentary questions
Question from Deputy Cathy Bennett - PQ 40025-26
Deputy Bennett asked about the reimbursement of risdiplam for adults living with spinal muscular atrophy (SMA). Read the HSE response.
From: Communications and public affairs
Published: May 2026
Updated: June 2026
Documents
Question from Deputy Cathy Bennett - PQ 40025-26
PDF, 449KB, 2 pages
Summary
To ask the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy (SMA); and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it